Priority Date: 16.03.12 (US 201261611810P)

BIOENGINEERED ALLOGENEIC BLOOD VESSEL

  • Application ID: EP13732217
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
active in Legal Services
Employment test 501 - 1000 employees
Company dna mintz levin cohn ferris glovsky and popeo pc
operating since 1933
Headquarter in Boston and 9 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC and Novitas Patent AB are specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 169 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 16.03.2012 - Priority Date (US 201261611810P)
  • 19.09.2013 - Publication A2 (WO2013136184)
  • 01.10.2014 - Publication A2 (EP2782995)
  • 09.11.2016 - Publication B1 (EP2782995)